[1]
Agarwal, S. and Mehta, S. 2024. Food and drug administration gives breakthrough: sanctioning of Rezdiffra for non-alcoholic steatohepatitis. International Journal of Advances in Medicine. 12, 1 (Dec. 2024), 155–155. DOI:https://doi.org/10.18203/2349-3933.ijam20243826.